207 related articles for article (PubMed ID: 32719950)
21. SRSF3 Is a Critical Requirement for Inclusion of Exon 3 of BIS Pre-mRNA.
Baek JY; Yun HH; Jung SY; Lee J; Yoo K; Lee JH
Cells; 2020 Oct; 9(10):. PubMed ID: 33086735
[TBL] [Abstract][Full Text] [Related]
22. Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3.
Ke H; Zhao L; Zhang H; Feng X; Xu H; Hao J; Wang S; Yang Q; Zou L; Su X; Wang L; Wu C; Wang Y; Nie J; Jiao B
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3426-E3435. PubMed ID: 29581274
[TBL] [Abstract][Full Text] [Related]
23. Splicing factor SRSF3 represses translation of p21
Kim J; Park RY; Kee Y; Jeong S; Ohn T
Cell Death Dis; 2022 Nov; 13(11):933. PubMed ID: 36344491
[TBL] [Abstract][Full Text] [Related]
24. SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells.
Kuranaga Y; Sugito N; Shinohara H; Tsujino T; Taniguchi K; Komura K; Ito Y; Soga T; Akao Y
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30279379
[TBL] [Abstract][Full Text] [Related]
25. B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer.
Ingebrigtsen VA; Boye K; Tekle C; Nesland JM; Flatmark K; Fodstad O
Int J Cancer; 2012 Dec; 131(11):2528-36. PubMed ID: 22473715
[TBL] [Abstract][Full Text] [Related]
26. LINC01210 promotes malignant phenotypes of colorectal cancer through epigenetically upregulating SRSF3.
Luo J; Gao K; Chen M; Tian B
Pathol Res Pract; 2022 Jun; 234():153905. PubMed ID: 35462226
[TBL] [Abstract][Full Text] [Related]
27. SRSF3 and HNRNPH1 Regulate Radiation-Induced Alternative Splicing of Protein Arginine Methyltransferase 5 in Hepatocellular Carcinoma.
Wen C; Tian Z; Li L; Chen T; Chen H; Dai J; Liang Z; Ma S; Liu X
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499164
[TBL] [Abstract][Full Text] [Related]
28. Loss of SRSF3 in Cardiomyocytes Leads to Decapping of Contraction-Related mRNAs and Severe Systolic Dysfunction.
Ortiz-Sánchez P; Villalba-Orero M; López-Olañeta MM; Larrasa-Alonso J; Sánchez-Cabo F; Martí-Gómez C; Camafeita E; Gómez-Salinero JM; Ramos-Hernández L; Nielsen PJ; Vázquez J; Müller-McNicoll M; García-Pavía P; Lara-Pezzi E
Circ Res; 2019 Jul; 125(2):170-183. PubMed ID: 31145021
[TBL] [Abstract][Full Text] [Related]
29. PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3.
Chen D; Zhao Z; Chen L; Li Q; Zou J; Liu S
Cell Death Dis; 2021 Jul; 12(8):722. PubMed ID: 34290239
[TBL] [Abstract][Full Text] [Related]
30. Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5.
Che Y; Bai M; Lu K; Fu L
Mol Carcinog; 2023 Feb; 62(2):210-223. PubMed ID: 36282044
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3.
Kim HR; Shin CH; Lee H; Choi KH; Nam DH; Ohn T; Kim HH
Oncotarget; 2017 Jan; 8(5):8342-8355. PubMed ID: 28039456
[TBL] [Abstract][Full Text] [Related]
32. B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway.
Jiang B; Liu F; Liu Z; Zhang T; Hua D
Tumour Biol; 2016 Jul; 37(7):9465-72. PubMed ID: 26787540
[TBL] [Abstract][Full Text] [Related]
33. B7-H3 upregulates BRCC3 expression, antagonizing DNA damage caused by 5-Fu.
Sun ZZ; Zhang T; Ning K; Zhu R; Liu F; Tang SC; Jiang B; Hua D
Oncol Rep; 2016 Jul; 36(1):231-8. PubMed ID: 27175567
[TBL] [Abstract][Full Text] [Related]
34. SRSF3/AMOTL1 splicing axis promotes the tumorigenesis of nasopharyngeal carcinoma through regulating the nucleus translocation of YAP1.
Xu XC; Jiang JX; Zhou YQ; He S; Liu Y; Li YQ; Wei PP; Bei JX; Sun J; Luo CL
Cell Death Dis; 2023 Aug; 14(8):511. PubMed ID: 37558679
[TBL] [Abstract][Full Text] [Related]
35. Exon 9 skipping of apoptotic caspase-2 pre-mRNA is promoted by SRSF3 through interaction with exon 8.
Jang HN; Lee M; Loh TJ; Choi SW; Oh HK; Moon H; Cho S; Hong SE; Kim DH; Sheng Z; Green MR; Park D; Zheng X; Shen H
Biochim Biophys Acta; 2014 Jan; 1839(1):25-32. PubMed ID: 24321384
[TBL] [Abstract][Full Text] [Related]
36. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
Yang S; Jia R; Bian Z
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.
Sun Y; Yan L; Guo J; Shao J; Jia R
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1133-1143. PubMed ID: 31515668
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of B7-H3 reverses oxaliplatin resistance in human colorectal cancer cells.
Zhang P; Chen Z; Ning K; Jin J; Han X
Biochem Biophys Res Commun; 2017 Aug; 490(3):1132-1138. PubMed ID: 28676400
[TBL] [Abstract][Full Text] [Related]
39. B7-H3 immune checkpoint expression is a poor prognostic factor in colorectal carcinoma.
Lu Z; Zhao ZX; Cheng P; Huang F; Guan X; Zhang MG; Chen HP; Liu Z; Jiang Z; Zheng ZX; Zou SM; Wang XS
Mod Pathol; 2020 Nov; 33(11):2330-2340. PubMed ID: 32514163
[TBL] [Abstract][Full Text] [Related]
40. SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells.
Gautrey H; Jackson C; Dittrich AL; Browell D; Lennard T; Tyson-Capper A
RNA Biol; 2015; 12(10):1139-51. PubMed ID: 26367347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]